Nivolumab vs Ondansetron

## Nivolumab vs Ondansetron: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Ondansetron**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Ondansetron**: Selective 5-HT3 receptor antagonist.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Ondansetron — 3-5 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Ondansetron — C18H19N3O.

**Molecular Weight**: Nivolumab — N/A; Ondansetron — 293.3660 g/mol.

**Type**: Nivolumab — Antibody; Ondansetron — Small molecule.